The study is published in the Proceedings of the National Academy of Sciences in an article titled, “Targeted degradation of ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the third quarter ...
These innovative approaches are notable for their capacity to integrate chemical, biological, and physical methodologies, optimizing the degradation of diverse pollutants while adhering to ...
University of California, Riverside scientists have designed novel agents that bind to and degrade Pin1, a protein linked to ...
KinCon biolabs now uses its technology to predict and this in living cells, whether drug candidates effectively bind to ...
In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins.
KinCon biolabs, a spin-off from the University of Innsbruck, is expanding its patented platform technology to support ...